Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Lauren Rusckowski Duprey currently holds 226,057 shares of TAKEDA PHARMACEUTICAL CO LTD (TAK), valued at approximately $0. This represents their equity stake as Chief Transformation Officer.
Based on SEC Form 4 filings, Lauren Rusckowski Duprey has been a net seller of TAK stock. They have purchased $0 and sold $813.7K worth of shares.
Lauren Rusckowski Duprey's most recent insider trade was on Aug 10, 2026, when they sold 47,586 shares at $17.10 per share.
Lauren Rusckowski Duprey serves as Chief Transformation Officer at TAKEDA PHARMACEUTICAL CO LTD (TAK). They have executed 3 insider transactions totaling $813.7K over their tenure at the company.
Lauren Rusckowski Duprey holds the position of Chief Transformation Officer at TAKEDA PHARMACEUTICAL CO LTD, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Lauren Rusckowski Duprey has shown a selling trading pattern, with $0 in total purchases and $813.7K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Lauren Rusckowski Duprey was on Aug 10, 2026, when they sold $813.7K worth of TAK shares. This transaction involved 47,586 shares at $17.10 per share.
Lauren Rusckowski Duprey currently owns 226,057 shares of TAKEDA PHARMACEUTICAL CO LTD (TAK), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Lauren Rusckowski Duprey's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Lauren Rusckowski Duprey has 3 Form 4 filings on record as an insider at TAKEDA PHARMACEUTICAL CO LTD.
Set alerts for Lauren Rusckowski Duprey and 40,000+ other insiders.